Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2015 Dec;22(12):1294-5.
doi: 10.1128/CVI.00497-15.

Immunosuppression in a Comparative Study of Feline Leukemia Virus Vaccines

Affiliations
Comment

Immunosuppression in a Comparative Study of Feline Leukemia Virus Vaccines

Hervé Poulet et al. Clin Vaccine Immunol. 2015 Dec.
No abstract available

PubMed Disclaimer

Comment in

Comment on

References

    1. Patel M, Carritt K, Lane J, Jayappa H, Stahl M, Bourgeois M. 2015. Comparative efficacy of feline leukemia virus (FeLV) inactivated whole-virus vaccine and canarypox virus-vectored vaccine during virulent FeLV challenge and immunosuppression. Clin Vaccine Immunol 22:798–805. doi: 10.1128/CVI.00034-15. - DOI - PMC - PubMed
    1. Tartaglia J, Jarrett O, Neil JC, Desmettre P, Paoletti E. 1993. Protection of cats against feline leukemia virus by vaccination with a canarypox virus recombinant, ALVAC-FL. J Virol 67:2370–2375. - PMC - PubMed
    1. Poulet H, Brunet S, Boularand C, Guiot AL, Leroy V, Tartaglia J, Minke J, Audonnet JC, Desmettre P. 2003. Efficacy of a canarypox virus-vectored vaccine against feline leukaemia. Vet Rec 153:141–145. doi: 10.1136/vr.153.5.141. - DOI - PubMed
    1. Hofmann-Lehmann R, Tandon R, Boretti FS, Meli ML, Willi B, Cattori V, Gomes-Keller MA, Ossent P, Golder MC, Flynn JN, Lutz H. 2006. Reassessment of feline leukaemia virus (FeLV) vaccines with novel sensitive molecular assays. Vaccine 24:1087–1094. doi: 10.1016/j.vaccine.2005.09.010. - DOI - PubMed
    1. Schlecht-Louf G, Mangeney M, El-Garch H, Lacombe V, Poulet H, Heidmann T. 2014. A targeted mutation within the feline leukemia virus (FeLV) envelope protein immunosuppressive domain to improve a canarypox virus-vectored FeLV vaccine. J Virol 88:992–1001. doi: 10.1128/JVI.02234-13. - DOI - PMC - PubMed

MeSH terms

LinkOut - more resources